Designed specifically for individuals with Phenylketonuria (PKU), Galen’s newest product, PKU Easy Microtabs Plus, provides a phenylalanine-free protein substitute, enriched with vitamins, minerals, and the essential and non-essential amino acids, which replaces the requirement for a separate vitamin and minerals supplement.
Speaking on the company’s announcement, President and Managing Director of Galen, Dr Dennise Broderick said: “PKU Easy Microtabs Plus has been developed by our team of dedicated pharmaceutical and nutritional professionals with the goal of making a real contribution to making daily lives of those affected with PKU a little easier. The release of this new product is testament to Galen’s commitment of providing extraordinary service to the patients and healthcare professionals we work with every day.
“This launch is the first in a pipeline of products being developed for Northern Europe, which will build on solid-dose protein substitute expertise across a range of metabolic disorders including Homocystinuria (HCU), Urea Cycle Disorder (UCD) and Maple Syrup Urine Disease (MSUD) that will give patients greater choice and support.”
Although PKU Easy Microtabs Plus is initially launching in the Nordics and Germany, Galen is planning a phased rollout of the product to the UK, USA and other regions within the next 18 months.
Simon Lawrence, Commercial Director of Galen’s Nordic Region commented: “We have listened to the feedback from our dietitians around combining vitamins and minerals to our existing PKU EASY Microtabs. We have also carefully formulated the product, with a coating to improve palatability (minimal taste and smell) for the patient and an inner matrix which results in the slow-release of amino acids, helping individuals with PKU to manage their condition effectively while also providing all the essential nutrients to ensure a healthy, balanced lifestyle for our patients.
“We are excited to provide a more manageable product to the PKU Community through this improved formulation which will make a difference to patients.”